|Articles|September 24, 2014
PHT's eDiary System Selected by Agile Therapeutics for Phase III Trial
PHT Corporation announced its LogPad System has been selected by Agile Therapeutics for use
Advertisement
PHT Corporation, a provider of technologies used to collect patient-driven eData for clinical research, says that its LogPad® System has been selected by Agile Therapeutics for use in its SECURE Phase III trial for its investigational product candidate, Twirla®. Agile's Senior VP of Clinical Development noted it chose the LogPad System for its proven track record of data quality and security, and comfort and convenience for patients, as well as PHT's leadership, experience and excellent customer service.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
2
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
5